Journal
NEUROPSYCHOPHARMACOLOGY
Volume 31, Issue 3, Pages 473-492Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.npp.1300958
Keywords
children; adolescents; suicide attempts; suicide; antidepressants; adults
Categories
Ask authors/readers for more resources
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
